Abstract:You have accessJournal of UrologyProstate Cancer: Basic Research II1 Apr 20121310 SUPPRESSION OF CD8+ T CELL INFILTRATION BY INCREASED TGF-β EXPRESSION IS ASSOCIATED WITH BIOCHEMICAL RECURRENCE IN PROSTATE CANCER PATIENTS WITH LOW GLEASON SCORES Qiang Zhang, Lin Chen, Brian Helfand, Vidit Sharma, Weijun Qin, Ximing J. Yang, Borko Jovanovic, Charles B. Brendler, Yinglu Guo, William Catalona, Chung Lee, and James Kozlowski Qiang ZhangQiang Zhang Chicago, IL More articles by this author , Lin ChenLin Chen Chicago, IL More articles by this author , Brian HelfandBrian Helfand Chicago, IL More articles by this author , Vidit SharmaVidit Sharma Chicago, IL More articles by this author , Weijun QinWeijun Qin Xian, China, People's Republic of More articles by this author , Ximing J. YangXiming J. Yang Chicago, IL More articles by this author , Borko JovanovicBorko Jovanovic Chicago, IL More articles by this author , Charles B. BrendlerCharles B. Brendler Chicago, IL More articles by this author , Yinglu GuoYinglu Guo Chicago, IL More articles by this author , William CatalonaWilliam Catalona Chicago, IL More articles by this author , Chung LeeChung Lee Chicago, IL More articles by this author , and James KozlowskiJames Kozlowski Chicago, IL More articles by this author View All Author Informationhttps://doi.org/10.1016/j.juro.2012.02.1657AboutPDF ToolsAdd to favoritesDownload CitationsTrack CitationsPermissionsReprints ShareFacebookTwitterLinked InEmail INTRODUCTION AND OBJECTIVES Transforming growth factorβ TGF-β) is a potent immunosuppressant molecule. We have previously reported that over-production of TGF-β by prostate cancer (PCa) cells results in suppression of CD8+ T cell infiltration into tumor parenchyma. In the current study, we continued to explore the correlation between tumor-derived TGF-β, CD8+ T cell infiltration, and PCa progression in men with seemingly indolent cancer [e.g. Gleason score (≤6)] in clinic. METHODS A total of 134 prostatectomy specimens with low Gleason score (≤6, LGS) were obtained from NU Prostate SPORE tissue bank. Levels of TGF-β, TGF-β receptors (TβRI and TβRII), p-smad2, and CD8+ cells were analyzed using both a high-throughput tissue microarray analysis and immunohistochemical staining. Statistical analyses were performed to compare the immunohistochemical findings and clinico-pathologic outcome including pre- and post-operative PSA levels of men included in the database (Median follow-up 120 months). Kaplan-Meier survival curves were constructed to assess the effect of infiltration of CD8+ T cells on biochemical recurrence. RESULTS High levels (75-100% positive staining cells), medium level (50-74% positive cell staining) and low level (<50% positive cell staining) of TGF-β expression were identified in 6.7%, 24.8% and 68.6% respectively of LGS tumors. There was decreased or no expression of TβR1 and TβRII in 12.5% and 12.4% of these tumors, respectively. CD8+ T cells were quantified in PCa tissue as follows: 96.4±21.1/high power field (hpf), 78.1±31.5/hpf and 38.7±13.6/hpf in low level, medium level and high level of TGF-β expression cases respectively. Elevated TGF-β1 expression inversely correlated with CD8+ T cell infiltration (p<0.05).This same pattern was true for TβRs expression. There was a positive correlation between the presence of CD8+ T cell and TβRI. In contrast, CD8+ T cell infiltration was inversely correlated with the tumor volume in the specimens. Low infiltration of CD8+ T cells was significantly associated with PSA recurrence after prostatectomy (p<0.01). CONCLUSIONS LGS PCa is generally recognized as indolent, and frequently does not correlate with patient prognosis. Our study suggested that disease recurrence is significantly associated with high levels of TGF-β and a lack of CD8+ T cells within tumor parenchyma. Assessing the magnitude of local TGF-β signaling and CD8+ T cell response in PCa tissue can potentially provide prognostic information that can be used to counsel patients with low grade disease. © 2012 by American Urological Association Education and Research, Inc.FiguresReferencesRelatedDetails Volume 187Issue 4SApril 2012Page: e531 Advertisement Copyright & Permissions© 2012 by American Urological Association Education and Research, Inc.MetricsAuthor Information Qiang Zhang Chicago, IL More articles by this author Lin Chen Chicago, IL More articles by this author Brian Helfand Chicago, IL More articles by this author Vidit Sharma Chicago, IL More articles by this author Weijun Qin Xian, China, People's Republic of More articles by this author Ximing J. Yang Chicago, IL More articles by this author Borko Jovanovic Chicago, IL More articles by this author Charles B. Brendler Chicago, IL More articles by this author Yinglu Guo Chicago, IL More articles by this author William Catalona Chicago, IL More articles by this author Chung Lee Chicago, IL More articles by this author James Kozlowski Chicago, IL More articles by this author Expand All Advertisement Advertisement PDF downloadLoading ...

Intratumoral LAG-3 + cells infiltration determines poor prognosis in patients with castration-naïve prostate cancer

LAG-3 Protein Expression in Non-Small Cell Lung Cancer and Its Relationship with PD-1/PD-L1 and Tumor-Infiltrating Lymphocytes.

The Clinicopathological Significance and Prognostic Value of Programmed Death-Ligand 1 in Prostate Cancer: a Meta-Analysis of 3133 Patients

Pan-cancer and single-cell analysis reveal dual roles of lymphocyte activation gene-3 (LAG3) in cancer immunity and prognosis

Stromal LAG-3+cells Infiltration Defines Poor Prognosis Subtype Muscle-Invasive Bladder Cancer with Immunoevasive Contexture

Lymphocyte activation gene 3 served as a potential prognostic and immunological biomarker across various cancer types: a clinical and pan‐cancer analysis

Intratumoral CXCL13+CD8+T cell infiltration determines poor clinical outcomes and immunoevasive contexture in patients with clear cell renal cell carcinoma

Prognostic Significance of Lymphocyte-activation Gene 3 (LAG3) in Patients with Solid Tumors: a Systematic Review, Meta-Analysis and Pan-Cancer Analysis.

Lpar1, Correlated With Immune Infiltrates, Is A Potential Prognostic Biomarker In Prostate Cancer

[Peripheral blood lymphocyte subsets are associated with the prognosis of prostate cancer]

High IL-23+ Cells Infiltration Correlates with Worse Clinical Outcomes and Abiraterone Effectiveness in Patients with Prostate Cancer

Presence of CD133-positive circulating tumor cells predicts worse progression-free survival in patients with metastatic castration-sensitive prostate cancer

High Intratumoral CD8+ T‐cell Infiltration is Associated with Improved Survival in Prostate Cancer Patients Undergoing Radical Prostatectomy

Lymphocyte-Activation Gene-3 Expression and Prognostic Value in Neoadjuvant-Treated Triple-Negative Breast Cancer.

CD8-positive T cells and CD204-positive M2-like macrophages predict postoperative prognosis of very high-risk prostate cancer

Intratumoral Foxp3+RORγt+ T Cell Infiltration Determines Poor Prognosis and Immunoevasive Contexture in Gastric Cancer Patients

MLXIPL Associated with Tumor-Infiltrating CD8+ T Cells is Involved in Poor Prostate Cancer Prognosis

Lymphocyte-activation gene 3 in non-small-cell lung carcinomas: correlations with clinicopathologic features and prognostic significance

1310 SUPPRESSION OF CD8+ T CELL INFILTRATION BY INCREASED TGF-β EXPRESSION IS ASSOCIATED WITH BIOCHEMICAL RECURRENCE IN PROSTATE CANCER PATIENTS WITH LOW GLEASON SCORES

Characterizing adipocytokine-related signatures for prognosis prediction in prostate cancer

Prognostic Implications of Blood Immune-Cell Composition in Metastatic Castration-Resistant Prostate Cancer